|
 |
| home > pmps > autumn 2002 > pharmaceutical industry through the introduction of radio frequency identification (rfid) technology |
 |
 |
PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Credit-card size radio frequency identification (RFID) 'smart tags' use their onboard memory to store information about a product or asset to which they are physically attached. This information can then be interrogated or updated automatically by radio signal. Consequently the location, history and status of every product in the warehouse - indeed the entire supply chain - can be known with precision.
Although 'smart tagging' is not a new technology, it is only recently that its deployment in large-scale logistics applications has become a practical proposition. This technology is now being proven in the field.
RFID tags comprise tiny computer chips fitted with antennas, ranging in size from a few millimetres to the size of a house brick. The passive variety require no onboard power supply and are particularly durable. Tags are programmed with information about an asset or product, and can be interrogated and updated simply by passing them through an electromagnetic field generated either by static portals placed at strategic points in the supply chain, or by hand-held terminals.
The main advantages of smart tags over conventional bar codes are that many items may be read or written to simultaneously, line-of-sight communication is not required and the tag information can be updated automatically at any point in the supply chain. As there is no need for manual data entry, the systems are highly efficient and virtually error-free. They also remove the potential for damage caused by the extra product handling involved in locating barcodes.
|
Read full article >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
 |
By Gordon McWilliams, Development Manager of Automation & Solutions at Tibbett & Britten Group plc
A graduate of the University of Glasgow in 1988, Gordon McWilliams was accepted by Tibbett & Britten as a graduate trainee the same year. He spent the early part of his career working on the Marks & Spencer contract before moving on to contracts with Sainsbury's, Foster's Menswear, Mars, Arcadia Group, Asda, The Chivas & Glenlivet Group and Unilever, among others.
After experience on the operational front line as general manager of three logistics facilities, he now works in business development in Tibbett & Britten's Technical Innovation Department, where he contributes to customer tender responses, research of new technologies, existing site developments and implementation of new business.
|
|
 |
 |
 |
|

 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
|